Documents
Application Sponsors
ANDA 203260 | HETERO LABS LTD V | |
Marketing Status
Application Products
001 | TABLET;ORAL | 100MG | 0 | LAMIVUDINE | LAMIVUDINE |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2014-01-02 | |
Submissions Property Types
TE Codes
CDER Filings
HETERO LABS LTD V
cder:Array
(
[0] => Array
(
[ApplNo] => 203260
[companyName] => HETERO LABS LTD V
[docInserts] => ["",""]
[products] => [{"drugName":"LAMIVUDINE","activeIngredients":"LAMIVUDINE","strength":"100MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] => [{"actionDate":"01\/02\/2014","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2014\\\/203260Orig1s000lbl.pdf\"}]","notes":""}]
[originalApprovals] => [{"actionDate":"01\/02\/2014","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2014\\\/203260Orig1s000lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2014\\\/203260Orig1s000ltr.pdf\"}]","notes":">"}]
[supplements] =>
[actionDate] => 2014-01-02
)
)